SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from SPARTA — Oct 19, 2005

SPARTA INC /DE (CIK 0000875623)
Date: Oct. 19, 2005 · CIK: 0000875623 · Accession: 0000892569-05-000925

AI Filing Summary & Sentiment

Referenced dates: August 30, 2005, September 29, 2005

Date
October 17, 2005
Author
/s/ DAVID E. SCHREIMAN
Form
CORRESP
Company
SPARTA INC /DE (CIK 0000875623)

Letter

Securities and Exchange Commission Division of Corporation Finance Attention: Ms. Nili Shah, Accounting Branch Chief SPARTA, Inc. Form 10-K for the fiscal year ended January 2, 2005 Filed April 1, 2005 File No. 0-21682

Re:

Dear Ms. Shah:

This letter sets forth the responses of SPARTA, Inc. to the Staff’s additional comments relating to our Annual Report on Form 10-K as of and for the year ended January 2, 2005 contained in your letter dated September 29, 2005 (the “Third Comment Letter”). The responses are numbered to correspond to the numbers of the comments in the Third Comment Letter.

Question 1

We note your response to comment 1 in our letter dated August 30, 2005. Specifically, we note your reference to Question 8 of the SEC “Frequently Asked Questions Regarding the Use of Non-GAAP Financial Measures (SEC FAQ). Question 8 states the following:

Companies should never use a non-GAAP financial measure in an attempt to smooth earnings. Further, while there is no per se prohibition against removing a recurring item, companies must meet the burden of demonstrating the usefulness of any measure that excludes recurring items, especially if the non-GAAP financial measure is used to evaluate performance.

It is permissible and may well be necessary to identify, discuss, and analyze material restructuring charges and other items, whether they are recurring or non-recurring, in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Depending on the nature and materiality of the charge or other item, it will likely be necessary to discuss the nature of such charges or other items, their recurring or non-recurring nature, their significance to an investor in evaluating the company’s financial condition and/or results of

October 17, 2005

Securities and Exchange Commission

Page 2

operations and whether they relate to material known trends, events or uncertainties that must be disclosed.

Whether an item may, or indeed must, be discussed in MD&A is a different question from whether it may be eliminated or adjusted in connection with a non-GAAP financial measure. Whether a non-GAAP financial measure that eliminates a recurring item or items from the most directly comparable GAAP financial measure is acceptable depends on all of the facts and circumstances. Such measures more likely would be permissible if management reasonably believes it is probable that the financial impact of the item will disappear or become immaterial within a near-term finite period. [Emphasis added.]

Based on the above guidance from the SEC FAQ, we do not disagree that your unallowable costs should be discussed in the MD&A. As noted in the second paragraph from Question 8, certain costs included within US GAAP measures may need to be identified, discussed and analyzed separately within MD&A. However, it does not appear to us that the need to discuss these costs necessarily warrants your non-GAAP measure presentation for an investor to obtain an understanding of your operating performance. The unallowable costs can be identified, discussed and analyzed separately from the US GAAP measures, gross profit and operating income, discussions.

In addition, Question 8 further states that non-GAAP measures eliminating recurring items may be more likely permissible, if you believe it is probable that the financial impact of the item will disappear or become immaterial within the near-term. In the government contracting arena with cost reimbursable contract vehicles being utilized, it does not appear that your unallowable costs will disappear or become immaterial. As such, it is difficult for us to understand how your non-GAAP measure is appropriate under Item 10(e) of Regulation S-K. Please reassess the guidance set forth in the SEC FAQ and revise your future filings.

Response to Question 1

As you have requested, we agree to revise our future filings to eliminate the disclosure of the non-GAAP financial measure.

* * * * *

If you have any questions regarding this response, please contact me at (703) 558-0036 or via facsimile to (703) 558-0046.

Sincerely,
/s/ DAVID E. SCHREIMAN

Show Raw Text
CORRESP
1
filename1.htm

corresp

October 17, 2005

Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

Attention: Ms. Nili Shah, Accounting Branch Chief

    Re:

    SPARTA, Inc.

Form 10-K for the fiscal year ended January 2, 2005

Filed April 1, 2005

File No. 0-21682

Dear Ms. Shah:

This letter sets forth the responses of SPARTA, Inc. to the Staff’s additional comments relating to
our Annual Report on Form 10-K as of and for the year ended January 2, 2005 contained in your
letter dated September 29, 2005 (the “Third Comment Letter”). The responses are numbered to
correspond to the numbers of the comments in the Third Comment Letter.

Question 1

We note your response to comment 1 in our letter dated August 30, 2005. Specifically, we note your
reference to Question 8 of the SEC “Frequently Asked Questions Regarding the Use of Non-GAAP
Financial Measures (SEC FAQ). Question 8 states the following:

Companies should never use a non-GAAP financial measure in an attempt to smooth earnings.
Further, while there is no per se prohibition against removing a recurring item, companies
must meet the burden of demonstrating the usefulness of any measure that excludes recurring
items, especially if the non-GAAP financial measure is used to evaluate performance.

It is permissible and may well be necessary to identify, discuss, and analyze material
restructuring charges and other items, whether they are recurring or non-recurring, in
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Depending on the nature and materiality of the charge or other item, it will likely be
necessary to discuss the nature of such charges or other items, their recurring or
non-recurring nature, their significance to an investor in evaluating the company’s
financial condition and/or results of

October 17, 2005

Securities and Exchange Commission

Page 2

operations and whether they relate to material known trends, events or uncertainties that
must be disclosed.

Whether an item may, or indeed must, be discussed in MD&A is a different question from
whether it may be eliminated or adjusted in connection with a non-GAAP financial
measure. Whether a non-GAAP financial measure that eliminates a recurring item or items
from the most directly comparable GAAP financial measure is acceptable depends on all of the
facts and circumstances. Such measures more likely would be permissible if management
reasonably believes it is probable that the financial impact of the item will disappear or
become immaterial within a near-term finite period. [Emphasis added.]

Based on the above guidance from the SEC FAQ, we do not disagree that your unallowable costs should
be discussed in the MD&A. As noted in the second paragraph from Question 8, certain costs included
within US GAAP measures may need to be identified, discussed and analyzed separately within MD&A.
However, it does not appear to us that the need to discuss these costs necessarily warrants your
non-GAAP measure presentation for an investor to obtain an understanding of your operating
performance. The unallowable costs can be identified, discussed and analyzed separately from the
US GAAP measures, gross profit and operating income, discussions.

In addition, Question 8 further states that non-GAAP measures eliminating recurring items may be
more likely permissible, if you believe it is probable that the financial impact of the item will
disappear or become immaterial within the near-term. In the government contracting arena with cost
reimbursable contract vehicles being utilized, it does not appear that your unallowable costs will
disappear or become immaterial. As such, it is difficult for us to understand how your non-GAAP
measure is appropriate under Item 10(e) of Regulation S-K. Please reassess the guidance set forth
in the SEC FAQ and revise your future filings.

Response to Question 1

As you have requested, we agree to revise our future filings to eliminate the disclosure of the
non-GAAP financial measure.

* * * * *

If you have any questions regarding this response, please contact me at (703) 558-0036 or via
facsimile to (703) 558-0046.

Sincerely,

/s/ DAVID E. SCHREIMAN

David E. Schreiman

Chief Financial Officer